QUICK LINKS
MAIN MENU
CONNECT WITH US

Clinical Trial Details

Title
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesion (ABSORB III)
Study Purpose
The pivotal trial to support the US pre-market approval (PMA) of Absorb BVS. ABSORB III will evaluate the safety and effectiveness of the Absorb BVS System compared to the XIENCE in the treatment of subjects, including those with diabetes mellitus, with ischemic heart disease caused by up to two de novo native coronary artery lesions in separate epicardial vessels.
Study Plan
Subjects will be randomized to treatment with the study device or an FDA approved stent.
Investigators

Principal Investigator
Theodore A. Bass, M.D.
Medicine

Sub Investigator
Dominick J. Angiolillo, M.D., Ph.D., FACC
Medicine

Sub Investigator
Martin "M" Zenni, M.D.
Medicine

Meeting Schedule & Submission Deadlines

Note: All submissions for IRB review require a single electronic copy of all documents to be emailed and a single (signed) original hardcopy be provided to the IRB office. The IRB cannot log in the submission until the paper copy is received.

Resources

News & Announcements

COMJ faculty mourn loss of esteemed colleague  - Thumb

COMJ faculty mourn loss of esteemed colleague

7/21/2017

Robert Wears, MD, PhD, was regarded as an expert in patient safety As faculty members toggle grief and shock over the death of Robert... [full story]

Cancer diagnosis data a focus during Celebration of Research  - Thumb

Cancer diagnosis data a focus during Celebration of Research

5/25/2017

On-campus research and discovery recognized at annual event H. Gilbert Welch, MD, MPH, says there’s a problem with cancer overd... [full story]

Angiolillo receives prestigious UFRF Professorship  - Thumb

Angiolillo receives prestigious UFRF Professorship

5/17/2017

Dominick Angiolillo, MD, PhD, remains humble and appreciative after receiving one of the most revered research-based accolades given by... [full story]

Upcoming Events

Sep 12

IRB Meeting

From 12:00 PM until 2:00 PM

Sep 19

IRB Meeting

From 12:00 PM until 2:00 PM